• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HK2是miR-148a的关键下游调节因子,对于维持宫颈癌细胞的成球特性和顺铂耐药性至关重要。

HK2 Is a Crucial Downstream Regulator of miR-148a for the Maintenance of Sphere-Forming Property and Cisplatin Resistance in Cervical Cancer Cells.

作者信息

Yang Hao, Hou Hui, Zhao Haiping, Yu Tianwei, Hu Yuchong, Hu Yue, Guo Junmei

机构信息

Department of Radiation Oncology, Inner Mongolia Cancer Hospital and Affiliated People's Hospital of Inner Mongolia Medical University, Hohhot, China.

Department of Pediatric Hematology and Oncology, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.

出版信息

Front Oncol. 2021 Nov 11;11:794015. doi: 10.3389/fonc.2021.794015. eCollection 2021.

DOI:10.3389/fonc.2021.794015
PMID:34858863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8631922/
Abstract

The acquisition of cancer stem-like properties is believed to be responsible for cancer metastasis and therapeutic resistance in cervical cancer (CC). CC tissues display a high expression level of hexokinase 2 (HK2), which is critical for the proliferation and migration of CC cells. However, little is known about the functional role of HK2 in the maintenance of cancer stem cell-like ability and cisplatin resistance of CC cells. Here, we showed that the expression of HK2 is significantly elevated in CC tissues, and high HK2 expression correlates with poor prognosis. HK2 overexpression (or knockdown) can promote (or inhibit) the sphere-forming ability and cisplatin resistance in CC cells. In addition, HK2-overexpressing CC cells show enhanced expression of cancer stem cell-associated genes (including and ) and drug resistance-related gene . The expression of HK2 is mediated by miR-145, miR-148a, and miR-497 in CC cells. Overexpression of miR-148a is sufficient to reduce sphere formation and cisplatin resistance in CC cells. Our results elucidate a novel mechanism through which miR-148a regulates CC stem cell-like properties and chemoresistance by interfering with the oncogene , providing the first evidence that dysregulation of the miR-148a/HK2 signaling plays a critical role in the maintenance of sphere formation and cisplatin resistance of CC cells. Our findings may guide future studies on therapeutic strategies that reverse cisplatin resistance by targeting this pathway.

摘要

癌症干细胞样特性的获得被认为是宫颈癌(CC)发生转移和产生治疗抗性的原因。CC组织中己糖激酶2(HK2)表达水平较高,这对CC细胞的增殖和迁移至关重要。然而,关于HK2在维持CC细胞的癌症干细胞样能力和顺铂抗性方面的功能作用,人们了解甚少。在此,我们发现CC组织中HK2的表达显著升高,且HK2高表达与预后不良相关。HK2过表达(或敲低)可促进(或抑制)CC细胞的成球能力和顺铂抗性。此外,HK2过表达的CC细胞中癌症干细胞相关基因(包括 和 )以及耐药相关基因 的表达增强。CC细胞中HK2的表达由miR - 145、miR - 148a和miR - 497介导。miR - 148a过表达足以降低CC细胞的成球能力和顺铂抗性。我们的结果阐明了一种新机制,即miR - 148a通过干扰癌基因 来调节CC干细胞样特性和化疗抗性,首次证明了miR - 148a/HK2信号通路失调在维持CC细胞成球能力和顺铂抗性中起关键作用。我们的发现可能为未来通过靶向该通路逆转顺铂抗性的治疗策略研究提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/a042a71377ff/fonc-11-794015-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/c33e3e86b03e/fonc-11-794015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/f0b0d59e5dc8/fonc-11-794015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/0fc07220fad3/fonc-11-794015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/3e8703e48e26/fonc-11-794015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/7be2751f7980/fonc-11-794015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/54da4b120429/fonc-11-794015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/8ccbacc86d45/fonc-11-794015-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/a042a71377ff/fonc-11-794015-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/c33e3e86b03e/fonc-11-794015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/f0b0d59e5dc8/fonc-11-794015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/0fc07220fad3/fonc-11-794015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/3e8703e48e26/fonc-11-794015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/7be2751f7980/fonc-11-794015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/54da4b120429/fonc-11-794015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/8ccbacc86d45/fonc-11-794015-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/8631922/a042a71377ff/fonc-11-794015-g008.jpg

相似文献

1
HK2 Is a Crucial Downstream Regulator of miR-148a for the Maintenance of Sphere-Forming Property and Cisplatin Resistance in Cervical Cancer Cells.HK2是miR-148a的关键下游调节因子,对于维持宫颈癌细胞的成球特性和顺铂耐药性至关重要。
Front Oncol. 2021 Nov 11;11:794015. doi: 10.3389/fonc.2021.794015. eCollection 2021.
2
MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.miR-148a 通过靶向 WNT10b 并调节顺铂耐药结直肠癌细胞中的 β-连环蛋白信号通路抑制细胞侵袭和迁移。
Biomed Pharmacother. 2019 Jan;109:902-909. doi: 10.1016/j.biopha.2018.10.080. Epub 2018 Nov 5.
3
Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.己糖激酶 2 通过增强顺铂诱导的自噬赋予卵巢癌细胞对顺铂的耐药性。
Int J Biochem Cell Biol. 2018 Feb;95:9-16. doi: 10.1016/j.biocel.2017.12.010. Epub 2017 Dec 13.
4
iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.iASPP通过miR-20a-FBXL5/BTG3信号通路诱导人宫颈癌发生上皮-间质转化并产生顺铂耐药性。
J Exp Clin Cancer Res. 2017 Apr 11;36(1):48. doi: 10.1186/s13046-017-0520-6.
5
LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis.长链非编码RNA-DANCR通过激活无氧糖酵解干扰miR-125b-5p/HK2轴,使结肠癌细胞对顺铂脱敏。
Front Oncol. 2020 Jul 17;10:1034. doi: 10.3389/fonc.2020.01034. eCollection 2020.
6
LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.长链非编码 RNA-SARCC 通过靶向己糖激酶 2 抑制 miR-143 介导的糖酵解来增强骨肉瘤对顺铂的敏感性。
Cancer Biomark. 2020;28(2):231-246. doi: 10.3233/CBM-191181.
7
miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.微小RNA-148a通过抑制INO80的表达来抑制甲状腺癌干细胞的自我更新。
Oncol Rep. 2016 Dec;36(6):3387-3396. doi: 10.3892/or.2016.5203. Epub 2016 Oct 25.
8
ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.由miR-148a-3p负调控的ATP酶铜转运蛋白A,在乳腺癌细胞中导致顺铂耐药。
Clin Transl Med. 2020 Jan;10(1):57-73. doi: 10.1002/ctm2.19. Epub 2020 Apr 7.
9
MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.微小RNA-125a-5p靶向LIM激酶1以抑制宫颈癌细胞的顺铂耐药性。
Oncol Lett. 2021 May;21(5):392. doi: 10.3892/ol.2021.12653. Epub 2021 Mar 18.
10
miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells.微小RNA-148a通过靶向肾癌细胞中的Rab14增加对顺铂的敏感性。
Int J Oncol. 2017 Mar;50(3):984-992. doi: 10.3892/ijo.2017.3851. Epub 2017 Jan 17.

引用本文的文献

1
Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulation.信号通路作为通过上调SOX2在肿瘤细胞中顺铂耐药的关键调节因子。
Med Oncol. 2025 Aug 22;42(10):437. doi: 10.1007/s12032-025-03004-9.
2
Warburg effect and lactylation in cancer: mechanisms for chemoresistance.癌症中的瓦伯格效应与乳酸化:化疗耐药机制
Mol Med. 2025 Apr 22;31(1):146. doi: 10.1186/s10020-025-01205-6.
3
Spatial transcriptomics reveals unique metabolic profile and key oncogenic regulators of cervical squamous cell carcinoma.

本文引用的文献

1
MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.微小RNA-148a-3p通过调节DNMT1和UTF1的表达水平来抑制宫颈癌细胞的增殖。
Oncol Lett. 2021 Aug;22(2):617. doi: 10.3892/ol.2021.12878. Epub 2021 Jun 24.
2
Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.长链非编码 RNA DLEU2 通过竞争性结合 miR-455 和调节 EZH2/miR-181a 通路,通过 HK2 驱动子宫内膜癌中的 EMT 和糖酵解。
J Exp Clin Cancer Res. 2021 Jun 26;40(1):216. doi: 10.1186/s13046-021-02018-1.
3
空间转录组学揭示了宫颈鳞状细胞癌独特的代谢特征和关键致癌调节因子。
J Transl Med. 2024 Dec 31;22(1):1163. doi: 10.1186/s12967-024-06011-y.
4
The impact of diabetes, hypercholesterolemia, and low-density lipoprotein (LDL) on the survival of cervical cancer patients.糖尿病、高胆固醇血症和低密度脂蛋白(LDL)对宫颈癌患者生存率的影响。
Discov Oncol. 2024 Aug 14;15(1):349. doi: 10.1007/s12672-024-01224-5.
5
The regulatory roles and clinical significance of glycolysis in tumor.糖酵解在肿瘤中的调控作用及临床意义。
Cancer Commun (Lond). 2024 Jul;44(7):761-786. doi: 10.1002/cac2.12549. Epub 2024 Jun 8.
6
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.糖酵解途径中的转录调控和翻译后修饰在靶向癌症治疗中的作用。
Acta Pharmacol Sin. 2024 Aug;45(8):1533-1555. doi: 10.1038/s41401-024-01264-1. Epub 2024 Apr 15.
7
Glucose metabolism reprogramming in gynecologic malignant tumors.妇科恶性肿瘤中的葡萄糖代谢重编程
J Cancer. 2024 Mar 17;15(9):2627-2645. doi: 10.7150/jca.91131. eCollection 2024.
8
Oncogenic Alterations of Metabolism Associated with Resistance to Chemotherapy.与化疗耐药相关的代谢致癌改变。
Curr Mol Med. 2024;24(7):856-866. doi: 10.2174/1566524023666230622104625.
9
The Role of Reprogrammed Glucose Metabolism in Cancer.重编程葡萄糖代谢在癌症中的作用。
Metabolites. 2023 Feb 25;13(3):345. doi: 10.3390/metabo13030345.
10
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.膀胱癌中的葡萄糖代谢重编程:己糖激酶2(HK2)作为膀胱癌治疗的预后生物标志物和靶点
Cancers (Basel). 2023 Feb 3;15(3):982. doi: 10.3390/cancers15030982.
Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters.
己糖激酶 2 在癌症中的作用:一个扮演多个角色的主角。
Int J Mol Sci. 2021 Apr 29;22(9):4716. doi: 10.3390/ijms22094716.
4
TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner.TIPE1以野生型p53依赖的方式促进宫颈癌细胞对顺铂的化疗耐药性。
Front Oncol. 2021 Jan 15;10:593615. doi: 10.3389/fonc.2020.593615. eCollection 2020.
5
Hexokinase 2 Promotes Cell Growth and Tumor Formation Through the Raf/MEK/ERK Signaling Pathway in Cervical Cancer.己糖激酶2通过Raf/MEK/ERK信号通路促进宫颈癌细胞生长和肿瘤形成。
Front Oncol. 2020 Nov 26;10:581208. doi: 10.3389/fonc.2020.581208. eCollection 2020.
6
Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.新型选择性己糖激酶 2 抑制剂苯并尼苯甲酰胺通过靶向糖酵解来阻断癌细胞生长。
Pharmacol Res. 2021 Feb;164:105367. doi: 10.1016/j.phrs.2020.105367. Epub 2020 Dec 8.
7
LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway.长链非编码RNA SNHG12通过miR-148a/CDK1途径调节宫颈癌的放射敏感性。
Cancer Cell Int. 2020 Dec 1;20(1):554. doi: 10.1186/s12935-020-01654-5.
8
LINC00662 contributes to the progression and the radioresistance of cervical cancer by regulating miR-497-5p and CDC25A.LINC00662 通过调控 miR-497-5p 和 CDC25A 促进宫颈癌的进展和放射抵抗。
Cell Biochem Funct. 2020 Dec;38(8):1139-1151. doi: 10.1002/cbf.3580. Epub 2020 Sep 1.
9
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.长链非编码RNA NNT-AS1通过NNT-AS1/miR-186/HMGB1轴促进宫颈癌顺铂耐药。
Cancer Cell Int. 2020 May 24;20:190. doi: 10.1186/s12935-020-01278-9. eCollection 2020.
10
MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.微小 RNA-361 通过抑制 HSP90 表达和 EMT 抑制宫颈癌,而癌基因 lncRNA NEAT1 则拮抗了这一作用。
Cells. 2020 Mar 5;9(3):632. doi: 10.3390/cells9030632.